Mibefradil dihydrochloride

This classification denotes a calcium channel blocker with the molecular formula C29H38FN3O3.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 842TUP3PQ8, chemically known as acetic acid, methoxy-, 2-(2-((3-(1h-benzimidazol-2-yl)propyl)methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenyl ester, dihydrochloride, (1s-cis)-, but more generally known as mibefradil dihydrochloride, which bears US NIH Compound Identifier 60662. European Medicines Agency schedules mibefradil dihydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08940MIG. Most nations, for tariff purposes, schedule mibefradil dihydrochloride under HS 29339990. As of Q4 2014, MIBEFRADIL DIHYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Mibefradil dihydrochloride bears US NLM identifiers UMLS ID C0286186 and NCI Concept Code C87687. SMILES: CC(C)[C@H]1C2CCC(CC2CC[C@@]1(CCN(C)CCCC3[NH]C4CCCCC4N3)OC(=O)COC)F.CL.CL.